| Exam Code/Number: | BPS-PharmacotherapyJoin the discussion |
| Exam Name: | Pharmacotherapy (Part1 and Part2) Exam |
| Certification: | BPS |
| Question Number: | 175 |
| Publish Date: | Jan 11, 2026 |
|
Rating
100%
|
|
Using a new assay, the following readings for Drug X concentration in a blood sample are obtained: 45 ng/mL, 43 ng/mL, 45 ng/mL, 44 ng/mL, 45 ng/mL, and 45 ng/mL. The true concentration of the drug was reported as 65 ng/mL using the gold-standard assay.
On the basis of these data, the new assay should be characterized in which of the following categories?
In which of the following scenarios should the error be reported to the Institute for Safe Medication Practices?
A 51-year-old male patient reports waking up in the middle of the night and being unable to go back to sleep, but he has no problem falling asleep. The patient says he feels exhausted most days of the Week at Work. His physician prescribes zolpidem 3.5 mg sublingually as needed.
What is the most appropriate counseling point about zolpidem for this patient?
A 24-year-old woman with bipolar disorder is admitted for arthroscopic surgery. Baseline laboratory studies reveal leukocytosis. Which drug is most likely to elevate WBCs and lead to an erroneous interpretation?
A 53-year-old patient with an 8-year history of diabetes is currently taking glipizide 10 mg twice daily before breakfast and supper. The patient weighs 85 kg and reports a 4.5 kg weight gain in the last year. Laboratory results are:
Creatinine: 1.2 mg/dL
A1C: 8.5%
What is the most appropriate recommendation at this time for improved diabetes control?